- Approval Id
- f012b81840e6d0b5
- Drug Name
- CRAVIT OPHTHALMIC SOLUTION 1.5% W/V
- Product Name
- CRAVIT OPHTHALMIC SOLUTION 1.5% W/V
- Approval Number
- SIN15047P
- Approval Date
- 2016-07-18
- Registrant
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Licence Holder
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- SOLUTION, STERILE
- Dosage
- <p><strong>DOSAGE AND ADMINISTRATION</strong><br>
Usually, instill 1 drop a time to the eye 3 times daily. The dosage may be adjusted according to the patient’s symptoms.</p>
- Route Of Administration
- OPHTHALMIC
- Indication Info
- <p><strong>INDICATIONS</strong><br>
<Indicated bacteria><br>
Susceptible strains of <em>Staphylococcus</em> sp., <em>Streptococcus</em> sp., <em>Streptococcus pneumoniae</em>, <em>Enterococcus</em> sp., <em>Micrococcus</em> sp., <em>Moraxella</em> sp., <em>Corynebacterium</em> sp., <em>Klebsiella</em> sp., <em>Enterobacter</em> sp., <em>Serratia</em> sp., <em>Proteus</em> sp., <em>Haemophilus influenzae</em>, <em>Haemophilus aegyptius</em> [Koch-Weeks bacillus], <em>Pseudomonas</em> sp., <em>Pseudomonas aeruginosa</em>, <em>Acinetobacter</em> sp., and <em>Propionibacterium acnes</em>.</p>
<p><Indications><br>
Blepharitis, dacryocystitis, hordeolum, conjunctivitis, tarsadenitis, keratitis (including corneal ulcer), and postoperative infections.</p>
<p><strong><Precautions related to Indications></strong></p>
<ol class="decimalparen">
<li>In order to avoid the emergence of resistant bacteria, bacterial susceptibility should be confirmed and treatment with this drug should be limited to the minimum period required for the eradication of the infection.</li>
<li>The efficacy of this product to methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) has not been proven. Therefore, other drug having a potent anti-MRSA activity should be administered immediately to patients positively infected with MRSA and not showing any improvement of symptoms with this product.</li>
</ol>
- Contraindications
- <p><strong>CONTRAINDICATIONS (This product is contraindicated in the following patients.)</strong><br>
Patients with a history of hypersensitivity to the ingredient of this product, ofloxacin or any quinolone antibiotics.</p>
- Atc Code
- S01AE05
- Atc Item Name
- levofloxacin
- Pharma Manufacturer Name
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Company Detail Path
- /organization/santen-pharmaceutical-asia-pte-ltd
